Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L

INTRODUCTION: A difference of ≥ 50–55 mg/dL between bedtime and morning glucose (BeAM) values in patients with type 2 diabetes (T2D) on basal insulin is an indicator of poor postprandial glucose control. This analysis compared the effect of treatment with a fixed-ratio combination of insulin glargin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zisman, Ariel, Dex, Terry, Roberts, Michelle, Saremi, Aramesh, Chao, Jason, Aroda, Vanita R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167304/
https://www.ncbi.nlm.nih.gov/pubmed/30218434
http://dx.doi.org/10.1007/s13300-018-0507-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167304/
https://www.ncbi.nlm.nih.gov/pubmed/30218434
http://dx.doi.org/10.1007/s13300-018-0507-0

Ejemplares similares